HOXD13 and acute myeloid leukemia: In sharp contrast to the observations with the AML1-ETO and MLL-AF9 models, atRA inhibited LSC activity in an AML mouse model driven by an Flt3-ITD in combination with a Nup98-Hoxd13 fusion gene [36].